REDWOOD CITY, Calif. (AP) _ Genomic Health Inc. (GHDX) on Tuesday reported first-quarter net income of $13 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the Redwood City, California-based company said it had profit of 34 cents.
The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 29 cents per share.
The cancer test maker posted revenue of $108.8 million in the period, also exceeding Street forecasts. Six analysts surveyed by Zacks expected $107.1 million.
Genomic Health shares have risen roughly 2% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $65.46, a rise of 81% in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GHDX at https://www.zacks.com/ap/GHDX